Newborn screening for blood disorders
Part of Blood & lymphatic clinical trials.
This study tests a screening program to detect inherited blood disorders in newborns at higher risk. Early detection can help manage treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a newborn
- Your baby must be considered at higher risk for a blood disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple blood test for newborn babies to find sickle cell disease early. If the test shows your baby has it, they can get care right away to stay healthier.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
This trial offers free genetic screening for rare diseases in newborns. It aims to find health conditions early so babies can get the right care sooner.
This study tests a new computer system to help hospitals quickly identify babies with sickle cell disease (an inherited blood disorder) right after birth or at early health visits. Finding sickle cell disease early helps prevent serious health problems and saves lives.
This study follows babies who had a positive newborn screening test for severe combined immunodeficiency (SCID), a rare condition affecting the immune system. The goal is to monitor their health over time to better understand and manage the condition.
This study tests a new way to track and share information about newborn sickle cell disease screening at health centers in your community. If your baby is under 1 year old, they may be able to get screened for sickle cell disease, a blood disorder, as part of this project.
Hear when a new SCD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.